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Despite early identification and aggressive modification of atherosclerotic risk factors, many patients still require surgical
revascularisation for established atherosclerotic vascular disease. However, bypass surgery is hampered by a high incidence
of vein graft failure. New strategies are being introduced to improve these results, with early data suggesting that
improved patency rates are possible. These vary from the use of adjuvant pharmacological agents and local gene transfer
strategies to the modification of vein harvesting techniques in order to reduce vascular damage to all layers of the graft.
Advances in vascular biology have resulted in new insights into the role of the endothelium and adventitia in vein graft
remodelling. Although recent pharmacological adjuvant therapy and molecular techniques have been described that may
be used to reduce the incidence of vein graft occlusion a more desirable approach for improved graft patency rates may
be achieved simply by using atraumatic surgical techniques aimed at minimising vascular damage during vessel harvesting
and subsequent anastamoses during bypass surgery.
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Introduction support the use of the internal mammary artery rather
than the saphenous vein where possible, as the conduit
Over the last 30 years coronary artery bypass surgery of choice for CABG.4,5 Suitable arteries are, however,
(CABG) has become a well-established means of re- not always available and the saphenous vein remains
vascularisation in patients with coronary artery dis- the most commonly used conduit.
ease. A number of venous and arterial grafts have Apart from its use in CABG, the saphenous vein is
been used, with varying degrees of success. The long also used in infrainguinal bypass procedures in
saphenous vein has been the vessel of choice for patients with critical limb ischaemia. Occlusion rates of
autologous vein graft since its use was first described saphenous veins used in both CABG and infrainguinal
by Favaloro in 1969.1 However, patency rates of venous bypass procedures are high, with reports of 15–30%
conduits are generally poor, compared with those of graft failure within one year, and approximately 50%
arterial grafts such as the internal mammary, gastro- grafts occluding within 10 years. This results in re-
epiploic and radial arteries, with early signs of graft currence of symptoms and complications including
occlusion appearing within months.2 An angiographic limb loss in peripheral vascular disease and death in
study comparing the patency of arterial and venous ischaemic heart disease. Potential causes and factors
grafts in 91 patients (receiving 194 arterial and 204 contributing to vein graft failure have been the subject
venous grafts) showed that progression of vessel oc- of numerous reviews, many of which focused mainly
clusion was more common in venous compared with on the endothelial cells lining the vessel lumen. In this
arterial grafts.3 These, and results from other studies, article we consider the contribution of vascular damage
to vein graft occlusion and how an increased effort in
developing atraumatic methods of surgical pre-
∗ Please address all correspondence to: M. R. Dashwood, Molecular paration and harvesting of veins may affect graftPathology and Clinical Biochemistry, Royal Free Hospital, Pond
Street, London NW3 2QG, U.K. patency.
1078–5884/02/030202+07 $35.00/0  2002 Elsevier Science Ltd. All rights reserved.
Recent Strategies to Reduce Vein Graft Occlusion 203
Fig. 1. Diagrammatic representation of vein graft occlusion. Different stages of vascular remodelling after vein graft surgery. 1. In ungrafted
vein there may appear a few nests of smooth muscle cells within the intima and some degree of medial fibrosis may be present. The
lumenal endothelium, lining the internal elastic lamina, will be continuous and the lumen patent. 2. Up to 1 week following graft
implantation the surgical preparation during vessel harvesting results in endothelial injury and denudation. Subsequent thrombus
formation occurs at regions where the intima is exposed. Adhesion of neutrophils and monocytes leads to the release of a range of factors
that can stimulate smooth muscle cell proliferation and migration. 3. Between 1 week and 1 month there will be signs of endothelial
regeneration with medial thickening occurring as a result of VSMC proliferation. VSMCs also migrate through the internal elastic lamina
and this leads to neointima formation. Macrophages may appear within the neointima. 4. Between 1 month and 3 years typical atheromatous
lesions may appear which are rich in foam cells and smooth muscle cells (characteristic of early atherosclerotic plaque formation). 5.
Beyond 3 years progressive intimal thickening occurs with formation of superimposed atheromatous plaques, resulting in narrowing of
the lumen. Plaque rupture may occur, leading to thrombotic graft occlusion. (Modified from Jeremy and Dashwood, 200152.)
Pathophysiology of Vein Graft Failure Failed grafts have, however, been found to exhibit
focal areas of intimal hyperplasia which do not gen-
Early vein graft failure occurs in up to 18% of sa- erally correlate to highly manipulated areas of vein
grafts such as sites of clamping, venotomies, valvesphenous vein grafts within the first month of im-
plantation.6,7 Within the first year up to 30% of both and tributaries.11 A majority of these areas occur in
the vein graft segment immediately adjacent to thecoronary and infrainguinal saphenous vein grafts oc-
clude, with subsequent occlusion rates of 2–3% per anastomosis.12 This juxta-anastomotic region may have
been subjected to increased intra-operative injury asyear.7,8 At 10 years, graft occlusion rates are more than
50%. The remaining patent grafts frequently show well as altered haemodynamics. Vascular damage and
increased shear stress at these and other areas ofangiographic lumenal irregularity or narrowing.
Early graft failure occurs mainly due to thrombotic vascular injury may also initiate the release and alter
levels of endothelium-derived substances such as nitricocclusions. Subsequently, the process of graft occlusion
involves the migration of medial vascular smooth oxide (NO), endothelin-1 (ET-1) and protacyclins
(PGI2), which may then act downstream resulting inmuscle cells (VSMC) of “contractile” phenotype to
the lumen of the graft, where they transform to a the development of further lesions distant to these
sites.“synthetic” phenotype, proliferating and secreting
extracellular matrix proteins to form a neointima.7,9
Atheromatous and fibrotic changes then occur over
the next decade in a process similar to wound-healing,
that may ultimately result in flow limiting stenosis or Animal Models of Vein Grafting
thrombotic occlusion of the graft10 (see Fig. 1).
The inevitable vascular trauma that occurs during A number of animal models have been used to in-
vestigate the pathophysiology of vein graft failurevein harvest is thought to contribute to graft failure.
In particular, clinical evidence and data from animal and to study potential methods for reducing graft
occlusion. Since intimal hyperplasia is observed instudies suggest that endothelial damage and/or dys-
function is associated with reduced graft patency. narrowed or occluded vein grafts, results from animal
models of arterial injury that are somewhat similar toHowever, damage to the tunica media and sur-
rounding tissue (including the tunica adventitia) of graft occlusion, are sometimes extrapolated to vein
grafts.13 However, models of arterial injury may notthe vessel also occurs and recent observations indicate
that adventitial remodelling and subsequent effects on be appropriate for studying changes in arterialised
veins grafts, consequently other animal models havemicrovessels (vasa vasorum) and vascular nerves may
also be important in the pathophysiology of vein graft been developed. For example, early cellular changes
in arterialised vein grafts have been studied using thenarrowing and occlusion.
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iliolumbar vein to iliac artery graft model14 and the denudation of the luminal endothelium, with sub-
sequent effects on vascular reactivity, thrombus for-epigastric vein to femoral artery interposition graft in
rats.15 The rat has also been used to study regeneration mation, cell proliferation22,23 and damage to the internal
elastic lamina and tunica media.24 Whilst it is re-of adrenergic nerves following transplantation of the
supradiaphramatic inferior vena cava into the ab- cognised that careful handling to reduce vascular
trauma is important during vein harvesting, ad-dominal aorta.16
Experimental models of vein grafts in larger animals ventitial damage still occurs due to stripping of the
perivascular tissue. This could contribute significantlyhave also been developed such as the porcine carotid
artery-saphenous vein17 and canine femoral artery- to graft occlusion since the adventitia contains the
majority of vascular nerves and the vasa vasorum, ainternal jugular vein interposition grafts.18 These mod-
els may be more relevant to the clinical situation, since microvessel network that provides the vessel wall with
oxygen and nutrients. There is also recent evidencethe general anatomy and vascular histology of these
species are closer to that described in man. However, that adventitial mass of vein grafts increases, and that
this is mainly due to the proliferation of fibroblastsin these models it is difficult to mimic the underlying
lipid abnormalities and atherosclerotic vascular dis- that are suggested to be progenitors of the neoin-
tima.25,26ease observed in humans, which contribute to vein
graft occlusion. Another potential limitation of these Modifications of surgical techniques have been at-
tempted to improve the results of vein graft surgery.models is that the type of graft and the techniques
used are not the same as those used in man. For
example, in the saphenous vein to carotid artery in-
Infrainguinal bypass graftsterposition graft model, the carotid artery does not
share the same characteristics as the coronary arteries,
In infrainguinal bypass procedures, the two main tech-which are exposed to different haemodynamic con-
niques employed are the in situ saphenous vein graftditions following bypass surgery. Furthermore, this
and the reversed graft. In the in situ graft techniquemodel generally uses end-to-end anastomoses and
the distal and proximal ends of the vein are exposed,may not be a suitable model to reflect the end-to-side
side branches ligated and valvular obstructions re-anastomoses used in man.
moved using a venous valvulotome. This techniqueRegardless of their limitations many of these models
has practical advantages: the calibres of the arterialare useful since these experimental grafts exhibit many
and venous segments of the proximal and distal ana-of the morphological changes seen in human vein graft
stomoses are better matched and the retained sub-failure and surgical/pharmacological interventions
cutaneous position of the vein facilitates graftmay be studied over relatively short time periods.
surveillance and repair, if needed. The adventitia and
associated vasa vasorum are also largely preserved
with this technique since the vein is not removed
from its vascular bed and this may contribute to
Methods of Reducing Vein Graft Occlusion graft patency (see below). However, the adventitia and
surrounding tissue are disrupted at the proximal and
Numerous methods have been attempted to reduce distal ends in order to carry out the anastomoses. In
vein graft occlusion. Apart from established adjuvant addition, the necessity for valve destruction results in
medical therapy,19 new pharmacological agents20 and significant endothelial and medial damage despite
gene therapy,21 various mechanical devices and modi- minimal handling or dissection of the vein, with con-
fication of conventional surgical techniques are pres- sequent risk of thrombosis, neointima formation and
ently undergoing evaluation. stenosis.
The in situ technique is only possible if the ipsilateral
saphenous vein is appropriate and of adequate length
and calibre. This is not always the case and may be
complicated by previous surgery, trauma or vari-Surgery
cosities. In such situations, the reversed vein graft is
used. In this technique the saphenous vein is harvestedDuring conventional surgical preparation of sa-
phenous vein for grafting, perivascular tissue is as previously described and reversed before ana-
stomosing the vein to the artery. Reversing the veinstripped from the vein and this results in venospasm
which is overcome by saline distention at pressures of graft prevents the valves from obstructing anterograde
flow.up to 600 mmHg. This procedure results in significant
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However, results from several randomised control
trials show that there is no significant difference in
patency rates using either the reversed or the in situ
vein graft.27
During vein harvesting, the vein is flushed and
distended to overcome venospasm and to check for
leakage. It is now recognised that distension causes
damage to the endothelium. Although different fluids
have been used to minimise damage including cold
heparinised blood, and balanced salt and albumin
solutions with heparin and papaverine, none of these
have been proven to have any beneficial effect on
outcome.
Coronary Artery Bypass Grafting (CABG)
In CABG, the importance of reducing surgical trauma
during preparation of the saphenous vein has been
recognised for many years. Different “atraumatic” or
“no-touch” techniques have been described to mini-
mise vein graft damage.28 These generally aim to re- Fig. 2. Histology of conventional and “Souza no-touch” veins.
Transverse sections of conventionally-prepared (A) and “Souza no-duce or avoid direct instrumentation of the vein during
touch” (B) saphenous vein, van Gieson stain (red stain identifiesharvesting. As mentioned above, venospasm is com- collagen and yellow vascular smooth muscle). Note the pronounced
mon following dissection and isolation of the vein and cushion of surrounding tissue in the “no-touch” vessel, which is
absent in conventionally harvested vein. This pedicle of tissueis overcome by hydraulic distension. Various phar-
contains a dense network of microvessels (vasa vasorum). Scalemacological agents have also been used topically or bar=1 mm.
intraluminally in an attempt to reduce venospasm.29
For example, papaverine in electrolyte solution or in
blood or albumin30 and glyceryl trinitrate-verapamil
solution31 have been found to reduce the pressures
required to overcome spasm during vein harvesting. that could impact favourably on graft patency. In
addition to being protective intra-operatively, the peri-The harvested vein is generally stored in colloidal
and/or vasodilating solutions with storage time kept vascular tissue that remains in place using this tech-
nique may act like an external stent (described later)to a minimum.
Recently a novel “no-touch” technique for vein graft- to reduce the effects of pulsatile pressure, altered flow
rates and shear stress that the arterialised vein ising has been described by Souza et al. where the
saphenous vein is harvested together with a cushion subjected to. Also, there is evidence that distension of
the saphenous vein required by conventional tech-of surrounding tissue (Fig. 2), with minimal handling
of the vessel.32 Apart from avoiding direct in- niques to overcome spasm causes endothelial de-
nudation and damage with associated loss ofstrumentation of the vein as in earlier “no-touch”
techniques, Souza’s technique also preserves the peri- endothelial NO synthase (eNOS).34 Distension is ob-
viated using Souza’s approach since spasm is notvascular tissue. Interestingly, no significant venospasm
is encountered using this technique and therefore no encountered,33 indeed scanning electron microscopy
has demonstrated improved endothelial integrity ofmechanical distension or pharmacological vasodilators
are required. Using this technique a graft patency rate grafts harvested by this technique compared with
those harvested conventionally.35 The adventitia is alsoof 95% was found on angiographic follow-up at 18
months,33 representing a three- to six-fold im- preserved using this new “no-touch” technique whilst
removal of perivascular tissue during conventionalprovement compared with conventional techniques of
CABG. Although the patient numbers are small, these harvesting technique results in significant adventitial
damage. Interestingly, NOS is also located within thepilot results are encouraging when compared to pat-
ency rates reported for current methods of surgery. intact adventitia of “no-touch” vein grafts and is as-
sociated with microvessels (vasa vasorum) and nervesSouza’s technique has several potential advantages
Eur J Vasc Endovasc Surg Vol 23, March 2002
J. C. S. Tsui and M. R. Dashwood206
of the graft38 and this may improve oxygenation of
otherwise hypoxic regions of the graft. Effects on the
levels of adventitial vasoactive factors, such as NO,
PGI2 and ET-1 may also be potential mechanisms by
which the stent acts. There is evidence that PGI2, cAMP
and cGMP are conserved at medial/intimal regions of
stented vein grafts and that adventitial formation of
these compounds is increased. NOS content and ac-
tivity within the adventitia of stented grafts is also
higher than in unstented grafts. The conservation and/
or stimulation of cyclic nucleotides may partly explain
the beneficial effects of external stents on vein graft
patency.39 ET-1 is a potent vasoconstrictor peptide that
also induces vascular smooth muscle proliferation.
This peptide and its receptors are increased in porcine
vein grafts17 suggesting that ET-1 may play a role in
altered vascular reactivity and smooth muscle cell
proliferation. The external stent reduces ET-1 levels
and this may represent another mechanism by which
this technique prevents vein graft hyperplasia. An-
other possibility is that the stent may affect (re-)
innervation of vein grafts since vascular smooth
muscle proliferation may be modulated by neuronal
factors.40 The potential contribution of the adventitia
to the success of both the external stent and Souza’s
“no-touch” technique suggests that this outer vascular
layer plays an important role in vein graft patency.Fig. 3. Localisation of microvessels and nerves in adventitia of
human saphenous vein. Microvessels (arrows) and vascular nerves
(N) in tunica adventitia of human saphenous vein. Microvessels
were identified immunohistochemically with CD31 (A) and nerves
with NF200 (B). The chromagen, diaminobenzidine, produces a
Potential Role of the Adventitia in Vein Graftbrown stain at regions of positive immunoreactivity. These abundant
microvessels, nerve fibres and paravascular nerve bundles that are Occlusion
located within the adventitia of saphenous veins are removed during
conventional harvesting for bypass surgery. Scale bar=50 m.
The tunica adventitia is the outermost layer of blood
vessels and since it gradually merges with the loose(Fig. 3).36 Preservation of these microvascular and neur-
connective tissue surrounding the vessel, this regiononal sources of NO in the native vessel, which are
is usually removed or damaged during conventionaldestroyed during conventional vein harvesting, may
harvesting of saphenous veins for use as bypass con-contribute to improved graft patency.
duits. In medium veins such as the saphenous vein, the
adventitia consists of longitudinally oriented bundles of
smooth muscle cells, collagen fibres and networks of
elastin fibres. Fibroblasts, macrophages and un-External stenting
myelinated nerves are also found within the adventitia
of medium and large veins. Adventitial microvesselsPlacement of a non-restrictive external stent around a
porcine vein graft prevents early neointima formation form the vasa vasorum which are responsible for pro-
viding oxygen and nutrients to the walls of large vessels.and medial thickening.37,38 The mechanisms underlying
this effect are unclear and are under investigation. In particular, venous blood is poorly oxygenated, there-
fore the vasa vasorum is important in supplying theInitially it was believed that the external stent reduces
the pulsatile stretch and shear forces to which the oxygen requirements of the cells of the venous wall.
Since venous pressure is low, the vasa vasorum canarterialised vein graft is exposed. This would reduce
the generation of endothelium- and tissue-derived approach the intimal layer without being collapsed by
the pressure within the vein. The vasa vasorum of veinsvasoactive factors possessing prothrombotic and pro-
liferative properties. Placement of an external stent penetrate much closer to the intima than the vasa
vasorum of arteries and this is particularly evident inalso promotes angiogenesis in the adventitial region
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